Addus HomeCare (NASDAQ:ADUS) Announces Quarterly Earnings Results

Addus HomeCare (NASDAQ:ADUS) posted its quarterly earnings data on Tuesday. The company reported $1.83 EPS for the quarter, topping the consensus estimate of $1.79 by $0.04, FiscalAI reports. Addus HomeCare had a net margin of 7.13% and a return on equity of 9.96%. The business had revenue of $387.74 million for the quarter, compared to analyst estimates of $388.72 million. During the same quarter in the previous year, the firm posted $1.56 earnings per share. Addus HomeCare’s quarterly revenue was up 7.0% on a year-over-year basis.

Addus HomeCare Trading Up 0.6%

Shares of NASDAQ:ADUS opened at $126.55 on Wednesday. Addus HomeCare has a 1 year low of $87.95 and a 1 year high of $127.08. The company has a debt-to-equity ratio of 0.05, a current ratio of 1.69 and a quick ratio of 1.69. The business’s 50 day moving average price is $117.22 and its 200-day moving average price is $106.62. The firm has a market capitalization of $2.36 billion, a price-to-earnings ratio of 22.20, a price-to-earnings-growth ratio of 1.79 and a beta of 0.75.

Analyst Upgrades and Downgrades

ADUS has been the subject of a number of recent research reports. Citigroup downgraded shares of Addus HomeCare from a “market outperform” rating to a “neutral” rating in a research report on Monday, September 14th. Raymond James Financial set a $137.00 price objective on shares of Addus HomeCare in a research report on Monday, September 28th. Bank of America cut Addus HomeCare from a “buy” rating to a “neutral” rating and dropped their target price for the company from $140.00 to $125.00 in a research report on Monday, September 14th. Royal Bank Of Canada raised their target price on shares of Addus HomeCare from $130.00 to $134.00 and gave the company an “outperform” rating in a research note on Wednesday, August 5th. Finally, Barclays boosted their target price on shares of Addus HomeCare from $92.00 to $96.00 and gave the stock an “underweight” rating in a research report on Wednesday, July 8th. One investment analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, Addus HomeCare presently has a consensus rating of “Moderate Buy” and an average price target of $129.33.

Addus HomeCare Company Profile

Addus HomeCare Inc (NASDAQ: ADUS) provides in-home personal care, hospice and home health services to older adults, people with disabilities and other individuals who need assistance with daily living or medical care. Its services are designed to help clients remain safely and independently in their homes while supporting families and caregivers.

The company’s personal care services include assistance with bathing, dressing, grooming, meal preparation, housekeeping and other activities of daily living.